510(k) K101203
K101203 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "TINA-QUANT ALBUMIN GEN 2". The FDA issued a decision of Substantially Equivalent on September 10, 2010. The device falls under product code DCF (Albumin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5040. Roche Diagnostics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 10, 2010
- Date Received
- April 29, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Albumin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5040
- Review Panel
- IM
- Submission Type